Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
61.63
+2.05 (3.44%)
Oct 20, 2025, 4:00 PM EDT - Market closed
Globus Medical Revenue
Globus Medical had revenue of $745.34M in the quarter ending June 30, 2025, with 18.37% growth. This brings the company's revenue in the last twelve months to $2.63B, up 17.43% year-over-year. In the year 2024, Globus Medical had annual revenue of $2.52B with 60.62% growth.
Revenue (ttm)
$2.63B
Revenue Growth
+17.43%
P/S Ratio
3.09
Revenue / Employee
$495,559
Employees
5,300
Market Cap
8.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.52B | 950.88M | 60.62% |
| Dec 31, 2023 | 1.57B | 545.63M | 53.34% |
| Dec 31, 2022 | 1.02B | 64.74M | 6.76% |
| Dec 31, 2021 | 958.10M | 169.06M | 21.43% |
| Dec 31, 2020 | 789.04M | 3.67M | 0.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
GMED News
- 3 days ago - Globus Medical Schedules Third Quarter Earnings Release and Conference Call - GlobeNewsWire
- 5 days ago - Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma - GlobeNewsWire
- 7 weeks ago - Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc. - GlobeNewsWire
- 2 months ago - Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Globus Medical Reports Second Quarter 2025 Results - GlobeNewsWire
- 3 months ago - Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results - GlobeNewsWire
- 3 months ago - Globus Medical Schedules Second Quarter Earnings Release and Conference Call - GlobeNewsWire
- 3 months ago - Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue - GlobeNewsWire